Cargando…

New developments in ablation therapy for hepatocellular carcinoma: combination with systemic therapy and radiotherapy

Detalles Bibliográficos
Autores principales:	Numata, Kauzshi, Wang, Feiqian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2022
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9577998/ https://www.ncbi.nlm.nih.gov/pubmed/36268250 http://dx.doi.org/10.21037/hbsn-22-363

Ejemplares similares

Combination Therapy With Lenvatinib and Radiofrequency Ablation for Patients With Intermediate-Stage Hepatocellular Carcinoma Beyond Up-To-Seven Criteria and Child–Pugh Class A Liver function: A Pilot Study
por: Wang, Feiqian, et al.
Publicado: (2022)

Safety and efficacy study: Short-term application of radiofrequency ablation and stereotactic body radiotherapy for Barcelona Clinical Liver Cancer stage 0–B1 hepatocellular carcinoma
por: Wang, Feiqian, et al.
Publicado: (2021)

Approach to systemic therapy in advanced hepatocellular carcinoma
por: Sankar, Kamya, et al.
Publicado: (2022)

Optimal application of stereotactic body radiotherapy and radiofrequency ablation treatment for different multifocal hepatocellular carcinoma lesions in patients with Barcelona Clinic Liver Cancer stage A4–B1: a pilot study
por: Wang, Feiqian, et al.
Publicado: (2021)

Combined locoregional and systemic therapy for advanced hepatocellular carcinoma: finally, the future is obscure
por: Farsad, Khashayar, et al.
Publicado: (2020)

Stereotactic body radiation therapy and radiofrequency ablation in patients with hepatocellular carcinoma: not a rival but a partner for the cure
por: Kim, Nalee, et al.
Publicado: (2022)

Providing meaningful survival benefit to hepatocellular carcinoma patients: combination therapy of future
por: Sarkar, Devanand
Publicado: (2022)

Combination therapies for advanced hepatocellular carcinoma: a beacon of light or a castle in the air
por: Rai, Vikrant, et al.
Publicado: (2022)

Hepatocellular carcinoma therapy finds a channel on the radio
por: Camacho, Javier
Publicado: (2019)

Combination transarterial chemoembolization and radiofrequency ablation therapy for early hepatocellular carcinoma
por: Song, Myeong Jun, et al.
Publicado: (2016)

Comparison of local ablative therapies, including radiofrequency ablation, microwave ablation, stereotactic ablative radiotherapy, and particle radiotherapy, for inoperable hepatocellular carcinoma: a systematic review and meta-analysis
por: Cheng, Po-Lung, et al.
Publicado: (2023)

Combination therapy of transcatheter arterial chemoembolization with axitinib for the treatment of inoperable hepatocellular carcinoma
por: Nouso, Kazuhiro, et al.
Publicado: (2020)

Gamma delta T cells in hepatocellular carcinoma: Sunrise of new therapy based on Vδ2 T cells?
por: Macek Jilkova, Zuzana
Publicado: (2022)

Adoptive Cell Therapy in Hepatocellular Carcinoma: A Review of Clinical Trials
por: Ozer, Muhammet, et al.
Publicado: (2023)

Combining immunotherapy and radiotherapy in hepatocellular carcinoma: the importance of irradiated tumor burden and the possible role of a low dose radiotherapy induction strategy
por: Grassberger, Clemens, et al.
Publicado: (2023)

Benefits of stereotactic ablative radiotherapy combined with incomplete transcatheter arterial chemoembolization in hepatocellular carcinoma
por: Paik, Eun Kyung, et al.
Publicado: (2016)

Current Understanding of Ablative Radiation Therapy in Hepatocellular Carcinoma
por: Mathew, Ashwathy S, et al.
Publicado: (2021)

Comment on: “A review on radiofrequency, microwave and high-intensity focused ultrasound ablations for hepatocellular carcinoma with cirrhosis”
por: Finotti, Michele, et al.
Publicado: (2022)

Safety and effectiveness of multi-antenna microwave ablation-oriented combined therapy for large hepatocellular carcinoma
por: Zhang, Tian-qi, et al.
Publicado: (2019)

Stereotactic Ablative Radiotherapy Fractionation for Hepatocellular Carcinoma in the United States
por: Sheth, Niki, et al.
Publicado: (2020)

Adjuvant atezolizumab-bevacizumab after curative therapy for hepatocellular carcinoma
por: Kudo, Masatoshi
Publicado: (2023)

New Biomarkers for Early Detection of Hepatocellular Carcinoma
por: Yoshida, Katsunori
Publicado: (2015)

Combination Therapy of Radiofrequency Ablation and Transarterial Chemoembolization for Unresectable Hepatocellular Carcinoma: A Retrospective Study
por: Tang, Chengwu, et al.
Publicado: (2016)

Locoregional Combined With Systemic Therapies for Advanced Hepatocellular Carcinoma: An Inevitable Trend of Rapid Development
por: Li, Xin, et al.
Publicado: (2021)

Melanoma: A model for testing new agents in combination therapies
por: Ascierto, Paolo A, et al.
Publicado: (2010)

Tips for Preparing and Practicing Thermal Ablation Therapy of Hepatocellular Carcinoma
por: Minami, Yasunori, et al.
Publicado: (2023)

Stereotactic Body Radiotherapy as a Salvage Therapy after Incomplete Radiofrequency Ablation for Hepatocellular Carcinoma: A Retrospective Cohort Study
por: Fu, Yizhen, et al.
Publicado: (2020)

Application of ablative therapy for intrahepatic recurrent hepatocellular carcinoma following hepatectomy
por: Cong, Rong, et al.
Publicado: (2023)

Microwave ablation in solitary hepatocellular carcinoma within 3–5 cm requiring consideration
por: Jiang, Lingmin, et al.
Publicado: (2023)

The Safety and Efficacy of Combination Therapy of Sorafenib and Radiotherapy for Advanced Hepatocellular Carcinoma: A Retrospective Study
por: Wada, Yoshiyuki, et al.
Publicado: (2017)

Diagnostic Value of Imaging Methods in the Histological Four Grading of Hepatocellular Carcinoma
por: Wang, Feiqian, et al.
Publicado: (2020)

Safety and efficacy of pentazocine–midazolam combination for pain and anxiety relief in radiofrequency ablation therapy for hepatocellular carcinoma
por: Nakano, Masanori, et al.
Publicado: (2022)

Systemic treatment of hepatocellular carcinoma: from sorafenib to combination therapies
por: Roderburg, Christoph, et al.
Publicado: (2020)

The Potential Implication of the Autonomic Nervous System in Hepatocellular Carcinoma
por: Parent, Romain, et al.
Publicado: (2019)

Results of surgical and percutaneous ablative therapy for hepatocellular carcinoma in elderly patients
por: Selvaggi, F, et al.
Publicado: (2010)

Long-term effect of stereotactic body radiation therapy for primary hepatocellular carcinoma ineligible for local ablation therapy or surgical resection. Stereotactic radiotherapy for liver cancer
por: Kwon, Jung Hyun, et al.
Publicado: (2010)

Roles of hypoxia-inducible factor in hepatocellular carcinoma under local ablation therapies
por: Xiao, Chunying, et al.
Publicado: (2023)

Comparison of Combination Stereotactic Body Radiotherapy Plus High-Intensity Focused Ultrasound Ablation Versus Stereotactic Body Radiotherapy Alone for Massive Hepatocellular Carcinoma
por: Wang, Lei, et al.
Publicado: (2018)

Non-Surgical Locoregional Therapies Alone or in Combination with Systemic Therapy in Patients with Hepatocellular Carcinoma
por: Chami, Perla, et al.
Publicado: (2023)

Uterine Fibroids: A Podcast on Patient and Physician Perspectives on Medical Management and a New Medical Therapy (Relugolix Combination Therapy)
por: Venable, Sateria R., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_sofv2sqbdeo7g99fedarkn1uvg